Vincamine (International)
Note: In some countries, this medicine may only be approved for veterinary use.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C04AX07
CAS registry number (Chemical Abstracts Service)
0001617-90-9
Chemical Formula
C21-H26-N2-O3
Molecular Weight
354
Therapeutic Categories
Vinca alkaloid
Cerebral vasodilator
Chemical Name
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, metyl ester, (3α,14β,16α)-
Foreign Names
- Vincaminum (Latin)
- Vincamin (German)
- Vincamine (French)
- Vincamina (Spanish)
Generic Names
- Vincamina (OS: DCIT)
- Vincamine (OS: BAN, DCF)
- Vincamine (PH: Ph. Franç. 11)
Brand Names
- Anacervix [+ Piracetam]
Angelini, Spain; Angelini, Portugal - Ao Bo Lan
Luyin Pharmaceutical, China - Brain Ox
October Pharma, Egypt - Candilat [+ Papaverine] [veterinary use]
Laboratoire TVM, France - Candilat RS [+ Heptaminol, + Papaverine] [veterinary use]
Laboratoire TVM, France - Candilat Veaux [+ Papaverine] [veterinary use]
Laboratoire TVM, France - Cebra
Rompharm, Georgia - Cervitam [+ Piracetam]
Egyphar, Egypt - Depotvinc
October Pharma, Egypt - Devincal [+ Piracetam]
Prodesfarma, Paraguay - Euroland [+ Cinnarizine]
Eurofarma, Argentina - Glatan
Aversi, Georgia - Oxybral
GlaxoSmithKline, Egypt; GlaxoSmithKline, Georgia - Oxybral SR
GlaxoSmithKline, Egypt - Oxyvin
GMP, Georgia - Vincabral
Neopharmi, Georgia - Vincabral SR
Pharco, Egypt - Vincaminã Biofarm
Biofarm, Romania - Vincamina ion
Ion, Uruguay - Vincapan
Sanofi-Aventis, Mexico - Vincarutine [+ Rutoside]
SERP, Monaco - Vincatreis
Ecobi, Italy - Vinebral
October Pharma, Georgia
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.